3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
2
Recruiting
2
Completed
1
Sponsor Class
OTHER
5
OTHER_GOV
2
NIH
2
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
2
Conditions
Breast Neoplasms
45
Neoplasms
27
Uterine Cervical Neoplasms
24
Prostatic Neoplasms
21
Carcinoma, Non-Small-Cell Lung
20
Colorectal Neoplasms
19
Stomach Neoplasms
18
Carcinoma, Hepatocellular
16
Multiple Myeloma
14
Ovarian Neoplasms
11
Recurrence
10
Pancreatic Neoplasms
10
Esophageal Squamous Cell Carcinoma
10
Esophageal Neoplasms
9
Leukemia, Myeloid, Acute
8
Endometrial Neoplasms
8
Lymphoma
7
Lung Neoplasms
7
Brain Neoplasms
7
Liver Neoplasms
6
Leukemia
6
Disease
6
Carcinoma, Ovarian Epithelial
6
Triple Negative Breast Neoplasms
5
Small Cell Lung Carcinoma
5
Rectal Neoplasms
5
Papillomavirus Infections
5
Colonic Neoplasms
5
Urinary Bladder Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Interventions
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Urination
1
Transurethral Resection of Prostate
1
Magnetic Resonance Spectroscopy
1
Finasteride
1
Dutasteride
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
OTHER_GOV
×
Prostatic Hyperplasia
×
Clear all
NCT06116851
2023-11-03
PROMIC
Turku University Hospital
Recruiting
300 enrolled
NCT06001619
2023-08-21
PROMED
Turku University Hospital
Phase 4
Recruiting
100 enrolled